Lyell Immunopharma

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LYEL and other ETFs, options, and stocks.

About LYEL

Lyell Immunopharma, Inc. operates as a holding company, which engages in the development of cell-based immunotherapies for human diseases. The company was founded by Richard D.

CEO

Elizabeth Homans

CEOElizabeth Homans

Employees

190

Employees190

Headquarters

South San Francisco, California

HeadquartersSouth San Francisco, California

Founded

2018

Founded2018

Employees

190

Employees190

LYEL Key Statistics

Market cap

1.81B

Market cap1.81B

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

984.18K

Average volume984.18K

High today

$7.69

High today$7.69

Low today

$7.24

Low today$7.24

Open price

$7.33

Open price$7.33

Volume

1.44M

Volume1.44M

52 Week high

$15.50

52 Week high$15.50

52 Week low

$3.57

52 Week low$3.57

LYEL Earnings

-$0.89

-$0.59

-$0.30

$0.00

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Nov 11, Pre-Market

ActualExpected Nov 11, Pre-Market

Lyell Immunopharma

Why Robinhood?

Lyell Immunopharma, Inc. operates as a holding company, which engages in the development of cell-based immunotherapies for human diseases. The company was founded by Richard D. Show more

LYEL Key Statistics

Lyell Immunopharma, Inc. operates as a holding company, which engages in the development of cell-based immunotherapies for human diseases. The company was founded by Richard D.